Author:
Xu Qinyuan Alis,Boerkoel Pierre,Hirsch-Reinshagen Veronica,Mackenzie Ian R.,Hsiung Ging-Yuek Robin,Charm Geoffrey,To Elliott F.,Liu Alice Q.,Schwab Katerina,Jiang Kailun,Sarunic Marinko,Beg Mirza Faisal,Pham Wellington,Cui Jing,To Eleanor,Lee Sieun,Matsubara Joanne A.
Abstract
AbstractAmyloid beta (Aβ) deposits in the retina of the Alzheimer’s disease (AD) eye may provide a useful diagnostic biomarker for AD. This study focused on the relationship of Aβ with macroglia and microglia, as these glial cells are hypothesized to play important roles in homeostasis and clearance of Aβ in the AD retina. Significantly higher Aβ load was found in AD compared to controls, and specifically in the mid-peripheral region. AD retina showed significantly less immunoreactivity against glial fibrillary acidic protein (GFAP) and glutamine synthetase (GS) compared to control eyes. Immunoreactivity against ionized calcium binding adapter molecule-1 (IBA-1), a microglial marker, demonstrated a higher level of microgliosis in AD compared to control retina. Within AD retina, more IBA-1 immunoreactivity was present in the mid-peripheral retina, which contained more Aβ than the central AD retina. GFAP co-localized rarely with Aβ, while IBA-1 co-localized with Aβ in more layers of control than AD donor retina. These results suggest that dysfunction of the Müller and microglial cells may be key features of the AD retina.
Funder
National Institute of Health
Canadian Institutes of Health Research
Brain Canada
Alzheimer Society Research Program
Michael Smith Foundation for Health Research
Foundation for Health Research and Precision Imaging Beacon
Genome Canada
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献